Icahn Tries To Rain On Genzyme's Investor Day Parade With Proxy Seeking Termeer's Ouster
This article was originally published in The Pink Sheet Daily
Executive Summary
Genzyme CEO and Chairman Termeer highlighted investor day presentation with five-point plan for enhancing shareholder value, including $2 billion stock repurchase plan.